Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Analysis of the Effectiveness and Safety of Lorlatinib in Untreated ALK-Positive NSCLC Patients in a French Real-World ContextALK+ Non-Small-Cell Lung CarcinomaRecruitingNot applicable2026-05-06NCT06487078

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Pfizer431

31 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Centre Hospitalier du Pays d AIXAix-en-ProvenceFrance1
Centre Hospitalier Francois MitterandPauFrance1
Centre Leon BerardLyonFrance70
CH ALBIAlbiFrance1
Ch Annecy GenevoisPringyFrance3
CH AvignonAvignonFrance7
CH CornouailleQuimperFrance2
Ch TroyesTroyesFrance1
CHBAVannesFrance1
CHICCréteilFrance1
Chits Ch Sainte MusseToulonFrance1
CHRU BretonneauToursFrance1
CHRU de NancyNancyFrance2
Chu Amiens SudAmiensFrance2
Chu LimogesLimogesFrance24
Chu NantesNantesFrance45
Clcc Georges Francois LeclercDijonFrance1
Clinique TeissierValenciennesFrance6
Hopital CochinParisFrance20
Hopital de RangueilTSA 50032 ToulouseFrance1
Hopital de Villefranche Sur SaoneGleizéFrance1
Hopital Europeen Georges PompidouParisFrance3
Hopital FochSuresnesFrance11
Hopital MorvanBrestFrance1
Hopital PontchaillouRennesFrance6